Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Hyperion Therapeutics Announces Results Of Phase I Study In Patients With Liver Cirrhosis
Hyperion Therapeutics, Inc. announced top-line results from a phase I study of HPN-100 in patients with liver cirrhosis. The data were presented as part of the 2009 Digestive Disease Week meeting. The abstract is titled "Pharmacokinetic (PK) and Safety Analyses of a Novel Ammonia-Reducing Agent in Healthy Adults and Patients with Cirrhosis."

Queensland Government Funds Univeristy Of Queensland Cancer Fight
University of Queensland (UQ) researchers will use a $5 million grant from the Queensland State Government to unlock the genetic causes of pancreatic and ovarian cancer.
News of the day
Fly Study Suggests Fasting May Not Be Key To Longer Life
Many studies on flies, mice, and more recently monkeys, have suggested that the key to a longer life is to restrict calorie intake, but a new study
Mental Health

International Society For Pharmaceutical Engineering Asks Pharma Professionals To Share Their Knowledge

ISPE, a global not-for-profit association of 25,000 pharmaceutical science and manufacturing professionals, announced that it is accepting proposals from pharmaceutical professionals for content that can be included in a variety of its educational res. "As a membership organization, ISPE truly relies on the contributions of dedicated and altruistic pharmaceutical professionals to advance their industry," said Robert P. Best, ISPE President and CEO. "Not only do these professionals enhance their credentials by contributing to Society publications, presentations, and res, but the knowledge they share makes a significant impact to benefit pharmaceutical manufacturing globally." ISPE is currently accepting proposals for webinar content, conference session topics; training courses; Pharmaceutical Engineering magazine and the Journal of Pharmaceutical Innovation articles; and technical document topics and materials. Submissions are expected to shed light on current, topical issues, and address knowledge gaps within the pharmaceutical science and manufacturing industry. In exchange for sharing knowledge, submitters will have the opportunity to network with, and learn from, fellow subject matter experts; gain additional experience and develop new skills; receive recognition from industry colleagues; and contribute to innovation while improving the efficiency of pharmaceutical industry processes. Contributions can be made by downloading the ISPE Proposal Form at http://www.ISPE.org/education. For more information, go to http://www.ISPE.org and click on Education and Training/Overview. International Society for Pharmaceutical Engineering


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009